Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
- 31 October 1998
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 352 (9138), 1413-1418
- https://doi.org/10.1016/s0140-6736(98)02309-5
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Phase II trial of irinotecan in patients with metastatic colorectal carcinoma.Journal of Clinical Oncology, 1997
- Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.Journal of Clinical Oncology, 1996
- Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancerBritish Journal of Surgery, 1995
- Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancerCancer, 1994
- Topoisomerase I inhibitors: topotecan and irenotecanCancer Treatment Reviews, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial.Journal of Clinical Oncology, 1992
- Prognostic variables in patients with hepatic metastases from colorectal cancer. Importance of medical assessment of liver involvementCancer, 1989